Fas ligand costimulates the in vivo proliferation of CD8+ T cells

I Suzuki, S Martin, TE Boursalian, C Beers… - The Journal of …, 2000 - journals.aai.org
I Suzuki, S Martin, TE Boursalian, C Beers, PJ Fink
The Journal of Immunology, 2000journals.aai.org
Abstract Fas ligand (FasL/CD95L/APO-1L) is one of a growing number of TNF family
members whose triggering costimulates maximal proliferation of activated T cells. In this
study we show that maximal Ag-dependent accumulation of transferred TCR-transgenic
CD8+ T cells requires Fas (CD95/APO-1) expression by the adoptive hosts. Additionally,
adoptively transferred FasL+ CD8+ T cells demonstrate a 2-fold advantage in Ag-driven
expansion over their FasL− counterparts. This study illustrates the in vivo role of TCR …
Abstract
Fas ligand (FasL/CD95L/APO-1L) is one of a growing number of TNF family members whose triggering costimulates maximal proliferation of activated T cells. In this study we show that maximal Ag-dependent accumulation of transferred TCR-transgenic CD8+ T cells requires Fas (CD95/APO-1) expression by the adoptive hosts. Additionally, adoptively transferred FasL+ CD8+ T cells demonstrate a 2-fold advantage in Ag-driven expansion over their FasL− counterparts. This study illustrates the in vivo role of TCR-dependent FasL costimulation in the Ag-specific proliferation of both heterogeneous and homogeneous populations of primary CD8+ T cells and long-term CTL lines. Thus, cross-linking FasL on naive and Ag-experienced CD8+ T cells whose Ag-specific TCRs are engaged is required to drive maximal cellular proliferation in vivo.
journals.aai.org